查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1668716

2025 年全球先进药物传输系统市场报告

Advanced Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年先进药物传输系统市场规模将强劲成长。到 2029 年，这一数字将成长至 4,042.6 亿美元，复合年增长率为 8.9%。预测期内的成长可归因于患者友善的给药途径、对罕见疾病的关注、数位健康整合、以患者为中心的药物开发、远端保健的影响、基因治疗和 RNA 治疗、基于外泌体的药物输送、远端监控设备等。预测期内的主要趋势包括奈米技术的进步、智慧药物传输系统、药物製剂的 3D 列印、人工智慧的整合以及永续的药物传输。

慢性病的增加预计将推动先进药物输送系统市场的扩张。慢性疾病是指持续时间超过一年且需要持续医疗照护的疾病，它是由多种危险行为引起的，包括吸烟、接触二手烟、营养不良、缺乏身体活动和过量饮酒。先进的药物输送系统在将治疗药物精确地输送到受慢性疾病影响的特定部位、提高疗效和最大限度地减少副作用方面发挥着至关重要的作用。例如，联合国（UN）2023年5月的资料显示，慢性病占美国死亡人数的十分之七，每年导致超过170万人死亡。因此，慢性病发病率的不断上升推动了先进药物输送系统市场的成长。

个人化医疗趋势可望推动先进药物输送系统市场的发展。个人化医疗，也称为精准医疗，考虑到个人在基因、环境和生活方式方面的差异，提供客製化的医疗服务。先进的药物传递系统有助于将药物精确地输送到患病细胞和组织，减少对健康器官的暴露并最大限度地减少副作用。 2023年2月，个人化医疗联盟报告称，个人化医疗占2022年美国食品药物管理局（FDA）核准的新药的34%，较前8年大幅成长。因此，对个人化医疗的日益倾向正在推动先进药物输送系统市场的发展。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球先进药物输送系统 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球先进药物输送系统市场：成长率分析
  • 全球先进药物输送系统市场表现：规模与成长，2019 年至 2024 年
  • 全球先进药物传输系统市场预测：规模与成长，2024-2029 年，2034 年预测
  • 先进药物输送系统的全球总目标市场 (TAM)

第六章 市场细分

  • 全球先进药物输送系统市场类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 口服药物传输系统
  • 注射药物输送系统
  • 吸入或肺部给药系统
  • 经皮给药系统
  • 粘膜给药系统
  • 基于载体的药物传输系统
  • 其他类型
  • 全球先进药物输送系统市场（按载体类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 脂质体
  • 奈米粒子
  • 微球
  • 单株抗体
  • 其他承运商类型
  • 全球先进药物输送系统市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 前驱药物
  • 植入和子宫内避孕器
  • 靶向药物输送
  • 聚合物药物输送
  • 其他技术
  • 全球先进药物传输系统市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 心血管疾病
  • 肿瘤学
  • 泌尿系统
  • 糖尿病
  • CNS（中枢神经系统）
  • 眼科
  • 发炎性疾病
  • 感染疾病
  • 其他用途
  • 全球先进药物输送系统市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科门诊
  • 临床研究发展中心
  • 全球先进药物输送系统市场，按口服药物输送系统类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 固态剂型
  • 液体剂型
  • 新型口服给药系统
  • 全球先进药物输送系统市场，依注射式药物输送系统类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 传统注射系统（注射器、管瓶）
  • 预填充式注射器
  • 自动注射器
  • 基于微针的系统
  • 全球先进药物输送系统市场，依吸入或肺部药物输送系统类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 定量喷雾吸入器(MDI)
  • 干粉吸入器 (DPI)
  • 喷雾器
  • 缓雾吸入器
  • 全球先进药物输送系统市场按经皮药物输送系统类型细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 经皮吸收贴片
  • 微针贴片
  • 离子电渗系统
  • 全球先进药物传输系统市场，依粘膜药物传递系统类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 口服给药系统
  • 舌下给药系统
  • 鼻腔给药系统
  • 直肠输送系统
  • 全球先进药物传输系统市场，依载体药物传递系统类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 脂质体
  • 奈米粒子
  • 树状聚合物
  • 囊泡
  • 全球先进药物输送系统市场，按类型细分，实际及预测，2019-2024 年，2024-2029 年，2034 年
  • 植入式药物传输系统
  • 标靶递送系统
  • 生物黏附药物传输系统

第七章 区域和国家分析

  • 全球先进药物输送系统市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球先进药物输送系统市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 先进药物输送系统市场：竞争格局
  • 先进药物输送系统市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Novartis AG
  • AstraZeneca plc
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • 3M Company
  • Medtronic plc
  • Eli Lilly and Company
  • Boehringer Ingelheim GmbH
  • Amgen Inc.
  • Merck Group
  • Becton Dickinson and Company
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi SA
  • Boston Scientific Corporation

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年先进药物输送系统市场：提供新机会的国家
  • 2029 年先进药物输送系统市场：提供新机会的细分市场
  • 先进药物输送系统市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r24624

Advanced drug delivery systems refer to innovative techniques and formulations designed to enhance the targeted distribution, bioavailability, and efficacy of pharmaceutical medications. These systems aim to maximize drug efficacy while minimizing side effects, providing controlled drug release rates, and targeting specific areas of the body.

The main types of advanced drug delivery systems include oral drug delivery systems, injection-based drug delivery systems, inhalation or pulmonary drug delivery systems, transdermal drug delivery systems, transmucosal drug delivery systems, carrier-based drug delivery systems, and others. The oral drug delivery system involves introducing a chemical through the mouth or into the gastrointestinal tract for systemic activity. Carrier types in these systems include liposomes, nanoparticles, microspheres, monoclonal antibodies, and others. Various technologies, such as prodrugs, implants, intrauterine devices, targeted drug delivery, polymeric drug delivery, and others, are employed. These delivery systems find applications in indications such as cardiovascular diseases, oncology, urology, diabetes, central nervous system (CNS) disorders, ophthalmology, inflammatory diseases, infections, and more. They are utilized by hospitals, specialized clinics, and clinical research and development centers.

The advanced drug delivery systems research report is one of a series of new reports from The Business Research Company that provides advanced drug delivery systems market statistics, including the advanced drug delivery systems industry's global market size, regional shares, competitors with advanced drug delivery systems market share, detailed advanced drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the advanced drug delivery systems industry. This advanced drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The advanced drug delivery systems market size has grown strongly in recent years. It will grow from $269.99 billion in 2024 to $287.82 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to improved patient compliance, drug patent expirations, personalized medicine, chronic disease prevalence, biologics and large molecule drugs

The advanced drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $404.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to patient-friendly routes of administration, focus on rare diseases, digital health integration, patient-centric drug development, telehealth influence, gene therapy and rna therapeutics, exosome-based drug delivery, remote monitoring devices. Major trends in the forecast period include nanotechnology advancements, smart drug delivery systems, 3d printing in drug formulations, integration of artificial intelligence, sustainable drug delivery.

The anticipated rise in chronic conditions is poised to drive the expansion of the advanced drug delivery systems market. Chronic conditions, persisting for a year or longer and necessitating ongoing medical care, are attributed to various risk behaviors such as tobacco use, exposure to secondhand smoke, poor nutrition, physical inactivity, and excessive alcohol use. Advanced drug delivery systems play a crucial role in precisely delivering therapeutic agents to specific sites affected by chronic conditions, enhancing drug effectiveness, and minimizing side effects. For example, as per May 2023 data from The United Nations (UN), chronic diseases account for seven out of 10 deaths in the US, causing over 1.7 million fatalities annually. Consequently, the increasing prevalence of chronic conditions underpins the growth of the advanced drug delivery systems market.

The shifting trend towards personalized medicine is anticipated to fuel the advancement of the advanced drug delivery systems market. Personalized medicine, also known as precision medicine, considers individual differences in genes, environments, and lifestyles for tailored medical care. Advanced drug delivery systems are instrumental in directing drugs precisely to diseased cells or tissues, reducing exposure to healthy organs and minimizing side effects. In February 2023, according to the Personalized Medicine Coalition, personalized drugs constituted 34% of new pharmaceuticals approved by the US Food and Drug Administration in 2022, marking a significant increase from the previous eight years. Therefore, the growing inclination towards personalized medicine is a driving force for the advanced drug delivery systems market.

Technological advancements represent a prominent trend in the advanced drug delivery systems market, with major companies embracing new technologies to maintain their market positions. In June 2023, Shilpa Medicare Limited, an India-based manufacturer and supplier of API and formulations, introduced Molshil, the world's first oral thin film formulation of a pediatric dose of paracetamol. This innovative paracetamol formulation boasts high palatability, ease of administration, and eliminates some disadvantages associated with pediatric formulations.

Major companies in the advanced drug delivery systems market are prioritizing strategic partnerships, such as those focused on indigenous drug delivery systems, to enhance efficacy and accessibility. These collaborations emphasize innovation and streamlined development processes. An indigenous drug delivery system leverages local resources and traditional knowledge to effectively administer therapeutic agents, prioritizing biocompatibility and cultural relevance, which can improve health outcomes in specific populations. For example, in June 2022, Gufic Biosciences, an India-based pharmaceutical company, introduced a Dual Chamber Bag (DCB). This system enhances drug delivery by ensuring safety and stability through a sterile, user-friendly design that reduces the risk of contamination and dosing errors. It also promotes indigenous production, making healthcare more affordable while improving the efficacy of reconstituted medications.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc., a US-based specialty pharmaceutical firm. Through this acquisition, Halozyme aims to strengthen its position as a top drug delivery firm, expanding its approach to covering specialized goods with its best-in-class auto-injector technology and specialty commercial business.

Major companies operating in the advanced drug delivery systems market include Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, Abbvie Inc., Bayer AG, Novartis AG, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, 3M Company, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Amgen Inc., Merck Group, Becton Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boston Scientific Corporation, Mylan N.V., Astellas Pharma Inc., Catalent Inc., Nipro Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation

North America was the largest region in the advanced drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the advanced drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The advanced drug delivery systems market consists of revenues earned by entities by providing stimuli-responsive drug delivery systems, sustained drug delivery systems, targeted drug delivery systems, and nanoparticle-based drug delivery systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced drug delivery systems market also consists of sales of fentanyl transdermal patches, albuterol inhalers, and hydrogels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Advanced Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on advanced drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation Or Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System; Other Types
  • 2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types
  • 3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
  • 4) By Application: Cardiovascular Diseases; Oncology; Urology; Diabetes; CNS (Central Nervous System); Ophthalmology; Inflammatory Diseases; Infections; Other Applications
  • 5) By End User: Hospitals; Specialized clinics; Clinical Research And Development Centers
  • Subsegments:
  • 1) By Oral Drug Delivery System: Solid Dosage Forms; Liquid Dosage Forms; Novel Oral Delivery Systems
  • 2) By Injection-Based Drug Delivery System: Conventional Injection Systems (Syringes, Vials); Prefilled Syringes; Autoinjectors; Microneedle-Based Systems
  • 3) By Inhalation Or Pulmonary Drug Delivery System: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers; Soft Mist Inhalers
  • 4) By Transdermal Drug Delivery System: Transdermal Patches; Microneedle Patches; Iontophoresis Systems
  • 5) By Transmucosal Drug Delivery System: Buccal Delivery Systems; Sublingual Delivery Systems; Nasal Delivery Systems; Rectal Delivery Systems
  • 6) By Carrier-Based Drug Delivery System: Liposomes; Nanoparticles; Dendrimers; Niosomes
  • 7) By Other Types: Implantable Drug Delivery Systems; Targeted Delivery Systems; Bioadhesive Drug Delivery Systems
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; Roche Holding AG; Abbvie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Advanced Drug Delivery Systems Market Characteristics

3. Advanced Drug Delivery Systems Market Trends And Strategies

4. Advanced Drug Delivery Systems Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Advanced Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Advanced Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Advanced Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Advanced Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Advanced Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Advanced Drug Delivery Systems Total Addressable Market (TAM)

6. Advanced Drug Delivery Systems Market Segmentation

  • 6.1. Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Drug Delivery System
  • Injection-Based Drug Delivery System
  • Inhalation Or Pulmonary Drug Delivery System
  • Transdermal Drug Delivery System
  • Transmucosal Drug Delivery System
  • Carrier-Based Drug Delivery System
  • Other Types
  • 6.2. Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liposomes
  • Nanoparticles
  • Microspheres
  • Monoclonal Antibodies
  • Other Carrier Types
  • 6.3. Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prodrug
  • Implants And Intrauterine Devices
  • Targeted Drug Delivery
  • Polymeric Drug Delivery
  • Other Technologies
  • 6.4. Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Oncology
  • Urology
  • Diabetes
  • CNS (Central Nervous System)
  • Ophthalmology
  • Inflammatory Diseases
  • Infections
  • Other Applications
  • 6.5. Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialized clinics
  • Clinical Research And Development Centers
  • 6.6. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Oral Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Dosage Forms
  • Liquid Dosage Forms
  • Novel Oral Delivery Systems
  • 6.7. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Injection-Based Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional Injection Systems (Syringes, Vials)
  • Prefilled Syringes
  • Autoinjectors
  • Microneedle-Based Systems
  • 6.8. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Inhalation Or Pulmonary Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered-Dose Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers
  • Soft Mist Inhalers
  • 6.9. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Transdermal Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transdermal Patches
  • Microneedle Patches
  • Iontophoresis Systems
  • 6.10. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Transmucosal Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Buccal Delivery Systems
  • Sublingual Delivery Systems
  • Nasal Delivery Systems
  • Rectal Delivery Systems
  • 6.11. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Carrier-Based Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liposomes
  • Nanoparticles
  • Dendrimers
  • Niosomes
  • 6.12. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Drug Delivery Systems
  • Targeted Delivery Systems
  • Bioadhesive Drug Delivery Systems

7. Advanced Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Advanced Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Advanced Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Advanced Drug Delivery Systems Market

  • 8.1. Asia-Pacific Advanced Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Advanced Drug Delivery Systems Market

  • 9.1. China Advanced Drug Delivery Systems Market Overview
  • 9.2. China Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Advanced Drug Delivery Systems Market

  • 10.1. India Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Advanced Drug Delivery Systems Market

  • 11.1. Japan Advanced Drug Delivery Systems Market Overview
  • 11.2. Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Advanced Drug Delivery Systems Market

  • 12.1. Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Advanced Drug Delivery Systems Market

  • 13.1. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Advanced Drug Delivery Systems Market

  • 14.1. South Korea Advanced Drug Delivery Systems Market Overview
  • 14.2. South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Advanced Drug Delivery Systems Market

  • 15.1. Western Europe Advanced Drug Delivery Systems Market Overview
  • 15.2. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Advanced Drug Delivery Systems Market

  • 16.1. UK Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Advanced Drug Delivery Systems Market

  • 17.1. Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Advanced Drug Delivery Systems Market

  • 18.1. France Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Advanced Drug Delivery Systems Market

  • 19.1. Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Advanced Drug Delivery Systems Market

  • 20.1. Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Advanced Drug Delivery Systems Market

  • 21.1. Eastern Europe Advanced Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Advanced Drug Delivery Systems Market

  • 22.1. Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Advanced Drug Delivery Systems Market

  • 23.1. North America Advanced Drug Delivery Systems Market Overview
  • 23.2. North America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Advanced Drug Delivery Systems Market

  • 24.1. USA Advanced Drug Delivery Systems Market Overview
  • 24.2. USA Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Advanced Drug Delivery Systems Market

  • 25.1. Canada Advanced Drug Delivery Systems Market Overview
  • 25.2. Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Advanced Drug Delivery Systems Market

  • 26.1. South America Advanced Drug Delivery Systems Market Overview
  • 26.2. South America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Advanced Drug Delivery Systems Market

  • 27.1. Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Advanced Drug Delivery Systems Market

  • 28.1. Middle East Advanced Drug Delivery Systems Market Overview
  • 28.2. Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Advanced Drug Delivery Systems Market

  • 29.1. Africa Advanced Drug Delivery Systems Market Overview
  • 29.2. Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Advanced Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Advanced Drug Delivery Systems Market Competitive Landscape
  • 30.2. Advanced Drug Delivery Systems Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Advanced Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. AstraZeneca plc
  • 31.3. Abbott Laboratories
  • 31.4. GlaxoSmithKline plc
  • 31.5. 3M Company
  • 31.6. Medtronic plc
  • 31.7. Eli Lilly and Company
  • 31.8. Boehringer Ingelheim GmbH
  • 31.9. Amgen Inc.
  • 31.10. Merck Group
  • 31.11. Becton Dickinson and Company
  • 31.12. Baxter International Inc.
  • 31.13. Teva Pharmaceutical Industries Ltd.
  • 31.14. Sanofi S.A.
  • 31.15. Boston Scientific Corporation

32. Global Advanced Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Advanced Drug Delivery Systems Market

34. Recent Developments In The Advanced Drug Delivery Systems Market

35. Advanced Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Advanced Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Advanced Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Advanced Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer